2023 Together - PP207A - Pharmacy Executives and Leaders

Las Vegas, NV US
September 20, 2023
Pharmacy leaders continue to face a myriad of challenges in today’s environment as healthcare organizations continue to strive to improve clinical care and value across the continuum. Presenters will share how they are tackling these challenges through the financial and workforce lens.  
 
Specifically:  
  • Financial challenges through a variety of projects and programs that touch on billing practices, sterile compounding and drug diversion 
  • Workforce challenges through the intersection of regulatory compliance and use of technology and mitigation strategies around maintaining a robust pipeline of pharmacy staff 
  • Rising to New Heights: Bold Strategies for growing revenue and ensuring patient safety  

Target Audience

  • Healthcare Executives
  • Healthcare Quality Professionals
  • Nurses
  • Pharmacists
  • Pharmacy Technicians
  • Physicians
  • Other Healthcare Professionals

Learning Objectives

  • Create a compelling case to resource system-level teams focused on sterile compounding standards compliance and drug diversion prevention. 
  • Identify various methods to maximize the financial opportunity associated with billing for waste 
Course summary
Available credit: 
  • 2.00 ACHE
  • 2.00 ACPE Pharmacist
  • 2.00 ACPE Pharmacy Technician
  • 2.00 AMA PRA Category 1 Credit™
  • 2.00 ANCC
  • 2.00 CPHQ – Certified Professional Healthcare Quality
  • 2.00 General CE - Attendance
  • 2.00 Interprofessional Continuing Education (IPCE)
Course opens: 
08/01/2023
Course expires: 
11/06/2023
Event starts: 
09/20/2023 - 9:45am CDT
Event ends: 
09/20/2023 - 11:45am CDT
Add to calendar: 
Wynn Las Vegas
3131 Las Vegas Blvd
Las Vegas, NV 89109
United States
Faculty
PP217 | Unleashing System Support for Diversion Prevention and Sterile Compounding 
Ryan Stice, PharmD, BCPS, Vice President, Pharmacy, Sutter Health, Sacramento, Calif. 
Melanie Horn, PharmD, BCSP, System Sterile Compounding Coordinator, Sutter Health, Sacramento, Calif. 
Teresa Liston-Crain, PharmD, DPLA, System Diversion Pharmacy Coordinator, Sutter Health, Sacramento, Calif. 
Deborah Simonson, BS, PharmD, CPEL, Chief Pharmacy Officer, Ochsner Health, New Orleans, La.  
Neil Hunter, PharmD, BCSCP, MBA, System Director, Sterile Compounding Operations, Ochsner Health, New Orleans, La.  
Alexandre Raymond, PharmD, MS, CHC, Director – Drug Diversion Prevention and Response, Compliance, Ochsner Health, New Orleans, La. 
 
PP227 | Optimization for Pharmaceutical Billing 
Steven Loborec, PharmD, MS, MPH, BCPS, Associate Director of Pharmacy, The Ohio State University Wexner Medical Center, Columbus, Ohio 
Eyal Yazdi, MBA, Associate Director of Pharmacy Business Operations, Yale New Haven Health System, New Haven, Conn. 
Marjorie Lazarre, MBA, PharmD, Associate Chief Pharmacy Officer, Yale New Haven Health System, New Haven, Conn. 
 
Disclosure
As an accredited provider of continuing education, Vizient, Inc. is dedicated to ensuring this activity presents learners with only accurate, balanced, scientifically justified recommendations, and is free from promotion, marketing, and commercial bias. In accordance with The Standards for Integrity and Independence in Accredited Continuing Education, all planners, faculty, and others in control of the educational content have disclosed the absence or existence of all financial relationships (of any dollar amount) with ineligible companies within the past 24 months.
 
Ineligible companies – those companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
It is Vizient’s policy that owners and employees of ineligible companies, and any individuals who refuse to disclose the absence or existence of financial relationships with any ineligible companies are disqualified from participating as planners or faculty.
 
FDA Off-Label Use
Faculty presenters are also expected to disclose any discussion of (1) off-label or investigational uses of FDA approved commercial products or devices or (2) products or devices not yet approved in the United States.
 
Disclosure Statements
Absence of Relevant Financial Relationships
None of the planners, faculty, or others in a position to control content for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

 

Accreditation Statement

In support of improving patient care, Vizient, Inc. is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
 
 

Credit Types

Interprofessional Continuing Education (IPCE)

This activity was planned by, and for, the healthcare team, and learners will receive 2.00 Interprofessional Continuing Education (IPCE) credits for learning and change.

 
 
Nurses (CNE)
Vizient, Inc. designates this live activity for a maximum of 2.00 ANCC contacts hours.
 
Pharmacists (CPE)
Vizient, Inc. designates this live activity for a maximum of 2.00 contact hours for Pharmacists. 
Universal Activity Number: JA0006103-0000-23-160-L04-P
 
Pharmacy Technicians (CPE)
Vizient, Inc. designates this live activity for a maximum of 2.00 contact hours for pharmacy technicians. 
Universal Activity Number: JA0006103-0000-23-160-L04-T
 
Physicians (CME)
Vizient, Inc. designates this live activity for a maximum of 2.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
 
Healthcare Executives (ACHE) 
By attending the 2023 Connections Summit offered by Vizient, Inc. participants may earn up to 2.00 ACHE Qualified Education Hours toward initial certification or recertification of the Fellow of the American College of Healthcare Executives (FACHE) designation.
 
Participants in this program who wish to have it considered for ACHE Qualified Education hours should list their attendance when they apply to the American College of Healthcare Executives for advancement or recertification. Participants are responsible for maintaining a record of their ACHE Qualified Education hours. To self-report, participants should log into their MyACHE account and select ACHE Qualified Education Credit.
 
Healthcare Quality Professionals (CPHQ)
This activity is approved by NAHQ® for 2.00 CPHQ CE credits.
 
Other Healthcare Professionals (General CE Credit)
Vizient, Inc. will award a maximum of 2.00 contact hours to all other healthcare professionals who successfully complete the activity. These individuals will receive a Certificate of Participation indicating the maximum credits available.
Many state licensing boards and credentialing bodies accept certificates of participation from accredited CE activities to meet CE requirements for license renewals and re-certification. It is the responsibility of the participant to contact their state licensing board and/or certifying body for verification on credit eligibility reciprocity.

 

Available Credit

  • 2.00 ACHE
  • 2.00 ACPE Pharmacist
  • 2.00 ACPE Pharmacy Technician
  • 2.00 AMA PRA Category 1 Credit™
  • 2.00 ANCC
  • 2.00 CPHQ – Certified Professional Healthcare Quality
  • 2.00 General CE - Attendance
  • 2.00 Interprofessional Continuing Education (IPCE)
Please login or register to take this course.

 

Select the Obtain Credit button to access the session evaluation and to claim CE Credit.